MUFG Securities EMEA’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-75,000
Closed -$4.44M 64
2015
Q3
$4.44M Buy
+75,000
New +$4.76M 1.7% 16

Other funds holding BMY

MUFG Securities EMEA's BMY Position: Q1 2026 in Review

MUFG Securities EMEA held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 83,471 shares worth $5.06M. The position accounts for 0.08% of the portfolio, ranked #167.

MUFG Securities EMEA first reported a position in BMY in Q4 2017 and has held it in 17 quarters since. The position peaked at $158M in Q1 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • MUFG Securities EMEA held 83,471 shares of Bristol-Myers Squibb worth $5.06M as of Q1 2026.
  • MUFG Securities EMEA left its Bristol-Myers Squibb share count unchanged in Q1 2026.
  • Bristol-Myers Squibb made up 0.08% of MUFG Securities EMEA's portfolio in Q1 2026, its #167 holding.
  • MUFG Securities EMEA first reported a position in Bristol-Myers Squibb in Q4 2017 and has held it in 17 quarters since.
  • MUFG Securities EMEA's Bristol-Myers Squibb position peaked at $158M in Q1 2019.
  • 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on MUFG Securities EMEA's 13F filing for Q1 2026, filed 11 May 2026.